This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Shortage Avoided

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%

OMEGA LABORATORIES LIMITED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% in Canada?

Yes. PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% 10MG has an active shortage reported to Health Canada (last updated September 23, 2026).

Why is PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% be available again?

The manufacturer's estimated resolution date is December 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength10MG

Last updated2024-01-03

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02238400

Strength

10MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

PHENYLEPHRINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2024-01-03

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% has 3 shortage/discontinuation reports on file — this is one of them.

2026-09-23

Active Shortage

Disruption of the manufacture of the drug.

2026-09-09

Active Shortage

Disruption of the manufacture of the drug.

Other Products from OMEGA LABORATORIES LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02150204

AMIKACIN SULFATE INJECTION

250MG · DIN 02486717

AMINOPHYLLINE INJ 25MG/ML

25MG · DIN 00582662

AMINOPHYLLINE INJ 50MG/ML

50MG · DIN 00582654

BAXEDIN 2% - 70%

DIN 02251477

BAXEDIN LIQ 20%

20% · DIN 00658413